p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas

International Journal of Cancer

Volumn 69, Issue 3, 1996, Pages 190-192

  Benhattar, Jean ^a,b   Cerottini, Jean Philippe ^a   Saraga, Emilia ^a   Metthez, Geneviève ^a   Givel, Jean Claude ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FLUOROURACIL; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE MUTATION; HUMAN; METASTASIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FLUOROURACIL; GENES, P53; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0030035584     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960621)69:3<190::AID-IJC7>3.0.CO;2-V     Document Type: Article

References (20)

1. BAUTISTA, D., CHAUBERT, P., BERTONCINI, J. and BENHATTAR, J., Detection of p53-gene mutation in cancer tissues by non-radioactive direct sequencing. PCR, Methods Applications, 4, 76-79 (1994).
2. BENGTSSON, G., CARLSSON, G., HAFSTROM, L. and JONSSON, P.E., Natural history of patients with untreated liver metastases from colorectal cancer. Amer. J. Surg., 141, 586-589 (1981).
3. BERGH, J., NORBERG, T., SJOGREN, S., LINDGREN, A. and HOLMBERG, L., Complete sequencing of the p53 gene provides prognostic information in breast-cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nature Medicine, 1, 1029-1034 (1995).
4. CAELLES, C., HELMBERG, A. and KARIN, M., p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (Lond.), 370, 220-223 (1994).
5. CLARKE, A.R., PURDIE, C.A., HARRISON, D.J., MORRIS, R.G., BIRD, C.C., HOOPER, M.L. and WYLLIE, A.H., Thymocyte apoptosis induced by p53-dependent and -independent pathways. Nature (Lond.), 362, 849-852 (1993).
6. EPSTEIN, R., Drug-induced DNA damage and tumor chemosensitivity. J. clin. Oncol., 8, 2062-2084 (1990).
7. FAN, S., EL-DEIRY, W.S., BAE, I., FREEMAN, J., JONDLE, D., BHATIA, K., FORNACE, A.J. JR, MAGRATH, I., KOHN, K.W. and O'CONNOR, P.M., p53-gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA-damaging agents. Cancer Res., 54, 5824-5830 (1994).
8. FEARON, E.R. and VOGELSTEIN, B., A genetic model for colorectal tumorigenesis. Cell, 61, 759-767 (1990).
9. GOH, H.S., YAO, J. and SMITH, D.R., p53 point mutation and survival in colorectal-cancer patients. Cancer Res., 55, 5217-5221 (1995).
10. HAFSTROM, L., ENGARAS, B., HOLMBERG, S.B., GUSTAVSSON, B., JONSSON, P.E., LINDNER, P., NAREDI, P. and TIDEBRANT, G., Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical trial. Cancer, 74, 2749-2756 (1994).
11. HAMELIN, R., LAURENT-PUIG, P., OLSCHWANG, S., JEGO, N., ASSELAIN, B., REMVIKOS, Y., GIRODET, J., SALMON, R.J. and THOMAS, G., Association of p53 mutations with short survival in colorectal cancer. Gastroenterology, 106, 42-48 (1994).
12. HICKMAN, J.A., Apoptosis induced by anti-cancer drugs. Cancer Metast. Rev., 11, 121-139 (1992).
13. HURLIMANN, J., CHAUBERT, P. and BENHATTAR, J., p53-gene alter-ations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques. Mod. Pathol., 7, 423-428 (1994).
14. KAPLAN, E.L. and MEIER, P. Non-parametric estimation from incomplete observations. J. Amer. Stat. Ass. B., 53, 457-481 (1958).
15. LOWE, S.W., BODIS, S., MCCLATCHEY, A., REMINGTON, L., RULEY, H.E., FISHER, D.E., HOUSMAN, D.E. and JACKS, T., p53 status and the efficacy of cancer therapy in vivo. Science, 266, 807-810 (1994).
16. LOWE, S.W., RULEY, H.E., JACKS, T. and HOUSMAN, D.E., p53-dependent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell, 74, 957-967 (1993).
17. RIOU, G., BARROIS, M., PROST, S., TERRIER, M.J., THEODORE, C. and LEVINE, A.J., Thep53 and mdm-2 genes in human testicular germ-cell tumors. Mol. Carcinog., 12, 124-131 (1995).
18. VALERI, A., MINI, E., TONELLI, P., VENERI, F., NERI, B., BORRELLI, D. and MAZZEI, T., Intra-arterial hepatic chemotherapy with 5-fluorouracil and 5-methyltetrahydrofolate in the treatment of unresectable liver metastases from colorectal cancer. Anticancer Res., 14, 2215-2219 (1994).
19. WAGNER, J.S., ADSON, M.A., VAN HEERDEN, J.A., ADSON, M.H. and ILSTRUP, D.M., The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann. Surg., 199, 502-508 (1984).
20. WATTEL, E., PREUDHOMME, C., HECQUET, B., VANRUMBEKE, M., QUESNEL, B., DERVITE, I., MOREL, P. and FENAUX, P., p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood, 84, 3148-3157 (1994).